drugset / Trial / NCT00476268

Efficacy and Tolerability of Beclometasone/Formoterol Single Inhaler in Patients With Moderate to Severe Persistent Asthma

NCT00476268

Phase 3 Completed 824 enrolled Chiesi Farmaceutici S.p.A.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Efficacy and tolerability of the fixed combination beclometasone/formoterol in patients with moderate to severe persistent asthma.

Timeline

Start
2004-02
Primary completion
2005-01
Completion
2005-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Beclomethasone Small molecule Inhaled
Comparator Formoterol Other / unclassified 12 ug Inhaled
Comparator beclomethasone dipropionate Other / unclassified 250 ug Inhaled

Indications